Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride doesn't raise acute pancreatitis risk.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Suppressing certain hormones might help prevent prostate cancer.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

A 69-year-old man with sinus infection and fainting spells was diagnosed with a rare kidney disease, treated with steroids and a specific drug, which improved his condition.

Finasteride and dutasteride reduce prostate cancer risk, but finasteride may increase higher-grade cancer risk.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Younger people (median age 35) experience more PFS-like symptoms with 1mg finasteride; more research needed.

A man's rash caused by Finasteride improved after stopping the drug and starting new treatments.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

Alpha-blocker therapy may not be needed long-term when combined with finasteride for BPH.

Hair loss can be an early sign of prostate enlargement.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Some common medications can lower PSA levels in 45-year-old German men.

Combining doxazosin and finasteride is more effective for managing benign prostatic hyperplasia than using either drug alone.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Treating hematospermia can improve sexual function and reduce anxiety.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

Antiandrogen therapy may be beneficial for women with hidradenitis suppurativa.

Finasteride causes fewer sexual side effects than dutasteride in men with BPH.

Male infertility often lacks thorough investigation, potentially missing reversible causes.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.